Biocon Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "S&P Global Places Biocon Biologics on Positive CreditWatchOn Account of Accelerated Debt Reduction".
Press Release Dec 11 2025
Filed with NSE · · 7 pages · English
Release
Earlier from Biocon
- Press Release Dec 06 2025
- Press Release Dec 02 2025
- Press Release Nov 11 2025
- Press Release Oct 23 2025
- Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V. (ustekinumab), a Biosimilar to Stelara®
Later from Biocon
- Press Release Dec 13 2025
- Biocon Limited Press Release Dec 15 2025
- Biocon Limited Press Release Dec 17 2025
- Biocon Limited Press Release Dec 23 2025
- Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon